Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Mar 2023
In a new study, researchers report the use of inhaled corticosteroids (HFNC) in patients with mild to moderate bronchiolitis...
Read Full NewsQurAlis reported interim ANQUR trial results showing target engagement, a biomarker signal, and a trend toward slower functional decline with QRL-201 in ALS.
Servier reported that sevasemten did not meet its primary or secondary endpoints in the pivotal GRAND CANYON trial for Becker muscular dystrophy.
GLP-1 RAs Linked to Lower Diabetes, CV Risk than Metformin in Prediabetes
1.
BRAF Inhibition in Pediatric Ameloblastoma of the Jaw
2.
Two Survival Wins in NSCLC With Bispecific Seeking Worldwide Status
3.
Venetoclax Combo Shows Promise in Younger Patients With AML
4.
Men With Prostate Cancer Experience Less Hot Flashes When Using an Affordable Drug.
5.
Cancer care crowdfunding increasingly common, but rarely successful
1.
Altered Tumor–Host Tissue Mechanics During Progressive Cancer Growth
2.
Exploring New Treatment Options for Hemophilia: A Journey into the Unknown
3.
A Comprehensive Guide To Understanding Plasma Osmolality
4.
Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer
5.
Exploring the Normal Range of Monocytes: A Comprehensive Guide
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Role of Multidisciplinary Cancer Care
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
5.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge